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Purpose: To investigate the direct relationship between the follicular fluid (FF) lev-
el of soluble human leukocyte antigen G (HLA-G) and fertilizability of the corre-
sponding oocyte as well as the morphological quality of the corresponding embryo. 
Materials and Methods: Sixty-three patients were stimulated with recombinant 
FSH combined with gonadotropin-releasing hormone (GnRH) agonist long (n=5) 
or antagonist protocol (n=58) for standard in vitro fertilization (IVF). At the time 
oocyte retrieval, follicular fluid was obtained from single dominant follicle in 63 
patients, and the level of soluble HLA-G was measured by sandwich enzyme-liked 
immunosorbent assay (ELISA). Normal fertilization and individual embryo quality 
were evaluated, and were graded to four categories by morphological criteria (the 
embryo with symmetrical blastomeres and no fragmentation were assigned as 
grade A). Good-quality embryo was defined as those with grade A or B. Results: 
Soluble HLA-G was not detected in 15 FF samples. In the group with positive FF 
soluble HLA-G (sHLA-G) (n=48), high levels of sHLA-G (>117.758 U/mL) could 
predict the failure of fertilization with statistical significance {area under the curve 
(AUC) 0.676, 95% confidence interval (CI) 0.525-0.804}. However, the FF sHLA-
G level was not related with the formation of good-quality embryo. Conclusion: 
High level of FF sHLA-G could predict the fertilization failure of the corresponding 
oocyte, but was not related with the formation of good-quality embryo.
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INTRODUCTION
Human leukocyte antigen G (HLA-G) is a non-classical HLA class I molecule ex-
pressed by extravillous trophoblast cells at the feto-maternal interface during preg-
nancy.1 Messenger RNA of HLA-G can be alternatively spliced into at least seven 
transcripts, which encode four membrane bound isoforms (G1, G2, G3, and G4) 
and three soluble isoforms (G5, G6, and G7).2 The proteolytic cleavage of surface 
isoform HLA-G1 generates the soluble HLA-G1 form (sHLA-G1). Both full-
length membrane-bound HLA-G1 and two soluble forms (sHLAG1 and HLA-
G5) have been shown to exert various immunosuppressive effects such as inhibit-Byung Chul Jee, et al.
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IVF treatment. The indications of IVF were identified as 
tubal (n=25), unexplained (n=20), male (n=7), diminished 
ovarian reserve (n=5), polycystic ovary syndrome (n=3), 
endometriosis (n=2), and uterine factor (n=1). The study 
was approved by the Institutional Review Board of Seoul 
National University Hospital to use stored FF samples.
Patients were stimulated with recombinant FSH (Gonal-
F; Merck-Serono, Geneva, Switzerland). The pituitary was 
suppressed by the gonadotropin-releasing hormone (GnRH) 
agonist long protocol (n=5) or GnRH antagonist protocol 
(n=58). For the GnRH agonist long protocol, daily injec-
tions of 0.1 mg triptorelin acetate (Decapeptyl; Ferring, 
Saint-Prex, Switzerland) were started in the mid-luteal 
phase of the previous cycle. After confirmation of pituitary 
down-regulation, gonadotropin injections were initiated on 
cycle day 2 or 3. The initial gonadotropin dose was fixed for 
the first 4 or 5 days, followed by adjustment on the basis of 
individual follicular growth and E2 levels until triggering. 
For the GnRH antagonist protocol, gonadotropin was start-
ed on cycle day 2 or 3. When the leading follicle reached a 
diameter of 14 mm, cetrorelix 0.25 mg (Cetrotide; Merck-
Serono) was added daily until triggering. 
Follicular growth was monitored by transvaginal ultra-
sound and serum E2 levels, which were started on day 4 or 
5 of the stimulation and repeated as appropriate. When at 
least three follicles reached 17 mm or two follicles reached 
18 mm in diameter, exogenous hCG (Ovidrel, Merck-Sero-
no) was administered and oocytes were retrieved transvagi-
nally 36 hrs later. At the time of oocyte retrieval, the single 
dominant follicle (>17 mm in diameter) was punctured. If 
one intact mature oocyte was present and the FF was not 
contaminated by visible blood, the FF was isolated. To pre-
vent contamination with other follicles, FF was collected 
from only one follicle for each ovary, and different needle 
was used for each side of the ovary. All FF samples were 
centrifuged immediately at 1,300 g for 10 min and the su-
pernatants were stored at -80°C until the assay.
IVF and subsequent culture of embryo were performed as 
previously reported.9 In each study subject, ejaculated sperms 
were used for fertilization. The mean of the total motile 
sperm count was 53.0×106. Intracytoplasmic sperm injection 
(ICSI) was used in nine cycles. Normal fertilization was de-
fined as those showing two distinct pronuclei. Non-fertilized 
oocyte or those with three pronuclei was considered as failed 
fertilization. Subsequently, individual embryo quality was 
evaluated at day 3 and graded by morphological criteria;
Grade A: symmetrical blastomeres and no fragmentation
ing the cytotoxic activity of CD8 positive T lymphocytes 
and natural killer (NK) cells, inducing the apoptosis of NK 
and activating cytotoxic T cells.1 Several lines of investiga-
tion indicate that the HLA-G molecule is involved in ma-
ternal acceptance of the semi-allogenic fetus during preg-
nancy and in the development of tolerance.2
Although sHLA-G is primarily expressed in the invading 
trophoblast cells, it can be detected in plasma or serum not 
only from pregnant women, but also from non-pregnant 
women. A low serum level of sHLA-G1 in the preovulatory 
period and during the first nine gestational weeks has been 
suggested as a risk factor for early abortion after in vitro 
fertilization (IVF).3 Complications during pregnancy, such 
as severe pre-eclampsia, spontaneous abortion, intrauterine 
growth retardation, and premature birth, are associated with 
a low or undetectable level of sHLA-G1 in the maternal 
blood circulation.4
Accumulating evidence supports the fact that preimplan-
tation human embryos can secrete sHLA-G into culture su-
pernatants and the levels may be predictive of their ability 
to implant.2,5 Soluble HLA-G is also found in follicular flu-
id (FF) where its presence has been linked to the presence 
in corresponding embryo culture supernatants.6 An immu-
nocytochemical study revealed that granulosa cells are re-
sponsible for production of sHLA-G.6,7 Soluble HLA-G mol-
ecules are detected also in supernatants of cumulus-oocyte 
complex (COC) that generates mature oocytes, but not in su-
pernatants of COCs that correspond to immature oocytes.8 
Because FF represents an essential and specific microen-
vironment for the regulation of ovarian function, a relation-
ship has been proposed between specific FF components 
and IVF outcome. However, the role of sHLA-G within FF 
remains still unknown. In the present study, we investigated 
the direct relationship between FF levels of sHLA-G and 
fertilizability of the corresponding oocyte as well as the 
morphological quality of corresponding embryo. 
MATERIALS AND METHODS
　　　
Our study involved 63 infertile women participating in IVF 
procedure between March 2007 and March 2010. The cy-
cle was included when at least one mature oocyte was ob-
tained and the corresponding FF from a single follicle was 
available. The averaged age was 34.4±3.3 years (range 27-
40). Fifty-one women were nulliparous including 33 who 
were nulligravid. Thirty women had no history of previous FF sHLA-G and Oocyte Quality
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cients of variation were 5.2% and 5.5%, respectively.
Statistical analysis was performed using MedCalc 4.15 
(MedCalc Software, Mariakerke, Belgium). Since the sub-
group data did not show a normal distribution, the Wilcox-
on test was used to compare the medians. Data are present-
ed as the median (25th percentile, 75th percentile). The Chi-
square test was used to compare proportions. The Spearman 
correlation test was used to assess degree of association be-
tween different parameters. Sensitivity and specificity were 
calculated, and the receiver operating characteristic (ROC) 
curve was plotted by changing the criteria of sensitivity and 
specificity. A p-value of <0.05 (two-tailed) was considered 
statistically significant.
RESULTS
 　
The overall fertilization rate was 84.1% (53/63). Using the 
ICSI procedure, seven of nine oocytes were normally fertil-
ized (77.8%), and the rate did not differ when compared 
with conventional IVF (85.2%, p=0.946). Soluble HLA-G 
was not detected in 15 FF samples. In the group with posi-
tive FF sHLA-G (n=48), the median concentration was 37.2 
U/mL (6.5, 135.5), and the fertilization rate was 85.4%. This 
rate was not statistically different from the negative FF sH-
LA-G group (80.0%, p=0.927). 
When fertilization occurred, the median concentration of 
positive FF sHLA-G was 35.5 U/mL (6.1, 118.2). In contrast, 
the median concentration was 173.3 U/mL (55.1, 187.8) 
when fertilization did not occur and the difference was not 
statistically significant (p=0.140). However, by using ROC 
curve analysis, high levels of sHLA-G (>117.758 U/mL) 
could predict the failure of fertilization with a statistical sig-
nificance (AUC 0.676, 95% CI 0.525-0.804, sensitivity 
Grade B: slightly uneven blastomeres and <20% frag-
mentation
Grade C: uneven blastomeres and >20% fragmentation
Grade D: uneven blastomeres and >50% fragmentation
Good-quality embryos were defined as those with mor-
phologic grade A or B. The embryo score was also calculat-
ed by multiplication of morphological grade of the embryo 
(Grade A=4, Grade B=3, Grade C=2, Grade D=1) by the 
number of blastomeres. 
All well-developed embryos were transferred to each pa-
tient’s uterus at day 3. The luteal phase was supported with 
daily intramuscular progesterone initially for 14 days start-
ing on the day of oocyte retrieval and continued for another 
6-8 weeks in cases where a pregnancy was achieved. A 
clinical pregnancy was defined by the presence of an intra-
uterine gestational sac with pulsating fetal heart beat 3-4 
weeks after oocyte retrieval.
The levels of soluble HLA-G in FF were estimated by en-
zyme-linked immunosorbent assay (ELISA) using commer-
cial sandwich ELISA kit (RD194070100R, BioVender, 
Czech Republic). The kit with monoclonal antibody could 
measure shed HLA-G1 and HLA-G5 in variable specimens. 
According to procedure described in manufacturer’s instruc-
tion, the samples were incubated with microplate wells pre-
coated with monoclonal anti-sHLA-G antibody. After 60 min 
of incubation and washing, monoclonal anti-human beta2-
microglobulin antibody labeled with horseradish peroxidase   
was added to the wells and incubated for 60 min with cap-
tured sHLA-G. A calibration curve was constructed by plot-
ting absorbance values against concentrations of calibrators, 
and concentrations of each sample were determined using 
the calibration curve. The FF was not diluted, and single 
measurement was performed in each sample. The limit of de-
tection was 3 U/mL, and the intra- and inter-assay coeffi-
Fig. 1. Left panel: the median concentration of follicular fluid soluble HLA-G was 35.5 U/mL (6.1, 118.2) in normal fertilization group and 173.3 U/mL (55.1, 187.8) 
in fertilization failure group (p=0.140, Wilcoxon test). Right panel: ROC curve analysis showed that high level of sHLA-G (>117.758 U/mL) could predict the fail-
ure of fertilization with a statistical significance (AUC 0.676, 95% CI 0.525-0.804, sensitivity 71.4%, specificity 75.6%, positive LR 2.93, negative LR 0.38). HLA-G, 
human leukocyte antigen G; ROC, receiver operating characteristic; AUC, area under curve; CI, confidence interval; LR, likelihood ratio.
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of different assay kits. Rizzo, et al.6 reported a 38% detec-
tion rate, while other researcher, using the same antibody, 
observed a positivity of 47%.7 However, none of them re-
ported the relation with oocyte fertilization potential and 
embryo quality. 
The assessment of oocyte quality is rapidly becoming 
one of the major objectives of embryologists in human IVF.11 
The potential use of non-invasive markers for selecting the 
best quality embryos in IVF is of immense importance, es-
pecially in countries like the UK where there is an increas-
ing move towards single embryo transfer to reduce multiple 
pregnancy rates. Currently, oocyte morphology is the most 
popular method for selecting competent oocytes. 
In the present study, we could not assess the direct rela-
tion between oocyte morphology and FF concentration of 
sHLA-G, because only good quality oocytes were studied. 
In conclusion, our findings indicate that FF sHLA-G testing 
could be used as an additional tool to assist oocyte selec-
tion. Further studies are required to fully understand the na-
ture of sHLA-G expression.
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